Nigeria, especially in areas like Jigawa state, has been contending with outbreaks, causing serious health worries.
Following the nationwide Human Papillomavirus (HPV) vaccination, and its introduction into the country’s routine immunization program, Gavi, the Vaccine Alliance,…
Dr. Muyi Aina and Dr. Kelechi Ohiri appointed as CEOs of NPHCDA and NHIA, tasked with ensuring equitable, world-class healthcare for all Nigerians.
The R21 vaccine is the second malaria vaccine recommended by WHO, following the RTS,S/AS01 vaccine, which received a WHO recommendation in 2021.
The decision to prioritise Nigeria for future malaria vaccine distribution will bridge a crucial healthcare gap in the nation’s battle against the pervasive disease.
The Federal Government has partnered Gavi and AFENET to reduce the number of children who have not received a single vaccine (zero dose children) across the country.
In remote areas of Niger State, Nigeria, tricycle ambulances are bridging the gap in maternal healthcare, providing vital transportation for expectant mothers and improving access to timely medical assistance during pregnancy and childbirth.
Despite contributing over 30 per cent of the malaria disease burden on the African continent, Nigeria has missed out of 18 million doses of first-ever malaria vaccines allocated to 12 African countries for 2023 to 2025.